1. Human Herperviruses Subfamily Alphaherpesvirinae
Herpes simplex virus 1 (HSV-1)
Herpes simplex virus 2 (HSV-2)
Varicella-zoster virus (VZV=HHV-3)
Subfamily Betaherpesvirinae
Cytomegalovirus (CMV=HHV-5)
Human herpes viruses 6, 7 (HHV-6, HHV-7)
Subfamily Gammaherpesvirinae
Epstein-Barr virus (EBV=HHV-4)
Human herpes virus 8 (HHV-8)

2. Alpha herpesviruses Short reproductive cycle; Rapid spread;
Multiplication in epithelial cells;
Latent in sensory ganglia;
Destruction of infected cells
HSV 1 and 2
VZV

3. Beta herpesviruses Long reproductive cycle; Slow infectivity;
Latent in monocytes, salivary glands, tonsils, kidneys;
Infected cells become large.
CMV
HHV6
HHV7

4. Gamma herpesviruses Infection specific to T or B lymphocytes;
Latent in lymphoid tissue, lymphocytes, salivary glands, epithelial cells of mouth and pharynx.
Proliferation of B-lymphocytes.
EBV
HHV 8

5. Herpes Simplex Viruses
- Herpetic gingivostomatitis;
- Herpes labialis (cold sore);
- Herpetic keratoconjunctivitis;
- Skin manifestations;
- HS meningitis and encephalitis;
- Genital herpes;
- Neonatal herpes.

6. Herpes virus structure
Ds linear DNA enveloped virus with icosahedral capsid.
Tegument contains viral proteins and enzymes for replication.

7. Glycoprotein "spikes" on the HSV surface.
Glycoprotein B (gB) is clearly visualised in clusters of spikes about 10 nm in length. Between the capsid and the envelope is an ill-defined layer of proteins, collectively known as the tegument.

8. Pathogenesis Transmission: - Contact of infected lesions;
- HSV 1 = oral-oral; oral-genital;
- HSV 2 = primarily genital-genital.
Local multiplication:
- Mucous membranes;
- No systemic illness.
Virus spread along neurons
Latent infection – sensory cranio-spinal ganglia

9. HSV1 can set up a primary infection in the lips, move to the trigeminal  ganglion where it can remain latent.
Virus can subsequently reactivate, move to the original site of infection and result in cold sores. Reactivation: physical or psychological stress, infection, fever, irradiation; including sunlight, and menstruation.

10. Site at which HSV-1 and HSV-2 cause disease in humans

11. Clinical manifestation
Gingivostomatitis occurs most frequently in children less than 5 years of age.
Symptoms:
fever, sore throat, pharyngeal edema and erythema,
vesicular or ulcerative lesions on the oral and pharyngeal mucosa.
Recurrent HSV infections of the oropharynx - herpes labialis (cold sores), usually appear on the vermillion border of the lip.
Gingivostomatitis looks different from a cold sore, occurs only once

12. Genital Herpes is caused by HSV 2 and HSV 1.
Primary infection usually involves:
In women: the vulva, vagina, and cervix.
In men: the glans penis, prepuce or penile shaft.
Clinical manifestation: fever, malaise, anorexia, bilateral inguinal lymphadenopathy, dysuria and urinary retention due to urethral involvement.
As many as 10 % of individuals develop an aseptic meningitis.
Recurrence – 60%.
The complete healing takes several weeks.

13. Clinical manifestation
Herpetic Keratitis
It is usually caused by HSV 1 and is accompanied by conjunctivitis.
The characteristic lesions are dendritic ulcers.
Deep stromal involvement may result in visual impairment.
Skin Manifestations
At any skin site.
Lesions on abraded skin of the fingers, known as herpetic whitlows.
Wrestlers because of physical contact may develop herpes gladiatorum.
Herpes Simplex Encephalitis
hemorrhagic necrosis of the inferiomedial portion of the temporal lobe.
clinical manifestations: headache, fever, altered consciousness, and abnormalities of speech and behavior.
mortality rate %.

14. Neonatal Herpes Simplex Virus Infection
It usually results from contact of the fetus with infected maternal genital secretions at the time of delivery.
Manifestations:
1) Skin, eye and mouth disease consists of cutaneous lesions and does not involve other organ systems.
2) Encephalitis.
3) Disseminated infection involves multiple organ systems and can produce disseminated intravascular coagulation, hemorrhagic pneumonitis, encephalitis, and cutaneous lesions.
The mortality rate:
- zero for skin, eye and mouth disease;
- 15 % for encephalitis;
- 60 % for neonates with disseminated infection.

15. Neonatal herpes infection

16. Laboratory Diagnosis Direct Detection:
Tzanck smear (multinucleated giant cells).
Immunofluorescence of skin scrappings.
PCR.
Virus Isolation on cell culture
Identification: IF, ELISA
Serology:
ELISA.
Used to document to recent infection.
CPE of HSV in cell culture: Note the ballooning of cells.

17. Varicella-zoster virus
Differs from HSV:
- Respiratory secretions transmission;
- Systemic disease;
- Rash itches;
- Latent in multiple sensory ganglia.
Live attenuated vaccine

18. Major Diseases Associated with HZV
Varicella or chicken pox
Zoster or shingles
Post-infectious encephalitis
Neonatal infection

20. The incubation period - from 11 to 23 days.
Varicella
Varicella or chickenpox is the manifestation of primary varicella-zoster virus infection.
The incubation period - from 11 to 23 days.
The rash begins on the face and trunk and spreads to the extremities.
The average duration of lesion formation is 3 to 5 days in the normal child; however, it is usually longer in adolescents, adults and in the immunocompromised
Latency - in the cerebral or posterior root ganglia.

21. Lesions appear in “crops’ on successive
days, so (unlike most rashes) all stages
of rash can be present at once:
papules, vesicles, scabs

22. Chicken pox

23. Herpes Zoster or shingles
is the recurrent form of varicella-zoster virus.
It is a reactivation of latent virus, manifests as a localized vesicular rash with a dermatomal distribution.
The virus reactivates in the ganglion and tracks down the sensory nerve to the area of the skin innervated by the nerve.
It is accompanied by intensive pain which may last for months (postherpetic neuralgia)

24. Shingles

25. Chickenpox of the newborn
The infant contracted chickenpox from her infected mother.
Congenital varicella syndrome:
Scarring of skin
Hypoplasia of limbs
CNS and eye defects
Death in infancy normal

26. Laboratory diagnosis of varicella zoster virus infections
Direct detection in skin lesions:
Tzanck smear (multinucleated
giant cells with nuclear inclusions).
Immunofluorescence.
PCR in the diagnosis of VZV meningoencephalitis from CSF.
Virus isolation from vesicle fluid on cell culture
CPE Identification: IF
Serology (IgG in paired acute and convalescent sera; IgM tests are likely to prove invaluable in determining the nature of congenital varicella infections):
ELISA, IF, CFT.

27. Cytomegalovirus Asymptomatic shedding: • Urine • Oral secretions
• Cervical secretions
• Semen
• Breast milk
No destruction of infected cells.
Cytomegaly.

28. Pathogenesis of cytomegalovirus
Routs of transmission:
- direct contact with infected body fluids: saliva, breast milk, urine;
- sexual intercourse;
- blood transfusions;
- respiratory;
- fecal-oral;
- trancplacentally;
- organ transplantation.
Infects epithelial cells and leukocytes.
Spread to all organs. Virus shed in body fluids many years.
Latent in neutrophils, monocytes, salivary glands, tonsils, kidneys.

29. Clinical manifestation
Congenital cytomegalovirus infection - 1 % of all live births.
Children acquire infection through:
contact with infected maternal genital secretions,
transplacentally,
breast milk.
Severe symptomatic disease:
hepatosplenomegaly,
myocarditis,
optic atrophy,
deafness,
pneumonitis,
involvement of the CNS.

30. Clinical manifestation
Mononucleosis-like syndrome.
in approximately 10 % of primary infections in older children and adults;
Manifestations:
fever,
malaise,
atypical lymphocytosis,
pharyngitis,
rarely, cervical adenopathy or hepatitis.

31. Clinical manifestation
Cytomegalovirus infection in severely immunocompromised individuals - life-threatening disease from either primary or reactivated infection.
Infection can involve:
lungs,
gastrointestinal tract,
liver,
retina,
CNS.
Individuals at high risk for severe disease (CMV pneumonia):
organ transplant recipients, particularly bone marrow transplant recipients,
individuals with human immunodeficiency virus infection.

32. Laboratory diagnosis of cytomegalovirus infection
Specimens: blood, breast milk, urine, saliva, liquor.
Methods:
- Nuclear inclusions (owl’s eyes) are surrounded by a clear halo that extends to the nuclear membrane
- PCR.
- Cultivation. Identification: IF, ELISA.
- Serology: IF, CFT, NtT.

33. Epstein-Barr virus Infectious mononucleosis.
Associated with human tumors:
Burkitt’s lymphoma;
Nasopharyngeal carcinoma;
B-lymphoma;
Hodgkin's lymphoma;
Hair-like oral leukoplakia

34. Pathogenesis Epstein-Barr virus infection
Transmission:
by contact with saliva, in particularly through kissing,
transfusions and organ transplantation can spread infected leukocytes.
Virus multiplies in:
epithelial cells of mouth,
local lymph tissue,
T- and B-lymphocytes.
Carriers shed virus for lifetime.

35. Clinical manifestation
Infectious mononucleosis.
The predominant findings:
malaise, fever,
pharyngitis,
cervical adenopathy,
splenomegaly.
A conjunctival hemorrhage of the right eye of a patient with infectious mononucleosis

36. Main symptoms of infectious mononucleosis

37. Burkitt's Lymphoma

38. Burkitt's Lymphoma
B-lymphoma

39. Host cell pathology No cytopathic effects. No inclusion bodies.
Virus can transform B cell cultures (proliferation)

40. Host immune response Stimulated (infected) B cells produce:
Polyclone immunoglobulins (heterphile Abs);
Viral membrane antigens.
Increase in activated T cells:
“Atypical lymphocytes”;
Abnormal lymphocytes in blood (Downy cells).
Cytotoxic T cells reduce number infected
B cells.
Immunosuppression = lymphomas.

41. Diagnosis EBV Histology: Downy cells (atypical lymphocytes).
Detection of heterophile antibodies:
Agglutinate sheep RBCs;
Serology:
Ig M against the Capsid Antigen = early;
Raising of the titer of the anti-EBV Nuclear Antigen.
3-6 weeks post infection

42. HHV-6 and 7
Transmission: through contact with saliva and breast feeding.
The main target cells are the T-lymphocyte and B-lymphocytes.
HHV-6 and HHV-7 become latent following primary infection and are reactivated from time to time, especially during periods of immunosuppression.
HHV-6 infection is firmly associated with:
roseala infantum,
meningitis, encephalitis,
symptoms in transplant recipients such as fever, liver and CNS manifestations.
HHV-6 and 7 is associated with chronic fatigue syndrome:
fatigue,
arthralgia,
sweating,
lymphadenopathy.

43. Rosealla infantum
most common in children age 6 months to 2 years.
The symptoms are respiratory illness, followed by a high fever (which can trigger seizures) for up to eight days. Fevers abruptly end and are followed by a rash on the trunk, then the extremities.

44. Human Herpes Virus 8
Is associated with Kaposi’s sarcoma, malignancies such as Castleman’s disease and primary effusion lymphomas.
HHV-8 DNA is found in almost 100% of cases of Kaposi’s sarcoma.
Most patients with KS have antibodies against HHV-8.
The seroprevalence of HHV-8 is low among the general population but is high in groups of individuals susceptible to KS, such as homosexuals.

45. Kaposi’s Sarcoma (HHV 8)
KS is a systemic disease that can present with cutaneous lesions with or without internal involvement. KS can involve the oral cavity, lymph nodes, and viscera of gastrointestinal and respiratory tract.
Morphologies of cutaneous lesions: macular, patch, plaque, nodular.
The AIDS-related KS lesions affect the upper trunk, face, and oral cavity
Transmission: through saliva (by kissing),
organ transplantation,
blood transfusion.

46. Treatment of herpesviruses infections
Acyclovir is the treatment of choice for:
mucocutaneous HSV infections,
herpes simplex encephalitis,
neonatal HSV infections,
varicella-zoster virus infections in the immunocompromised individuals.
Valaciclovir, and famciclovir is the treatment for shingles.
Ganciclovir and foscarnet are used for the treatment of cytomegalovirus infection in
immunocompromised individuals.

47. Mechanism of action of acyclovir
In cell acyclovir develops in mono-, dy- and three phosphate.
The first step is induced by viral timidinkinase, following phosphorilation cellular kinase induce. Produced acycloguanosinthreephosphate inhibits viral DNA-polymerase and so nucleic
acid synthesis.
Hence, acyclovir does not
inhibit DNA synthesis in
noninfected cells because
of absence of its active form.